Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
Advances in Gamma Knife Treatment for Brain Metastases
Cleveland Clinic Cancer Advances
19 minutes
3 weeks ago
Advances in Gamma Knife Treatment for Brain Metastases
Radiation oncologist in the Burkhardt Brain Tumor and Neuro-Oncology Center and Associate Director of the Gamma Knife Center, Samuel Chao, MD, joins the Cancer Advances podcast to talk about how advances in Gamma Knife radiosurgery are transforming treatment for patients with brain metastases. Hear how innovations in imaging, staging, and safety are allowing clinicians to treat more lesions while preserving brain function.
Cleveland Clinic Cancer Advances
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
